Eikon Therapeutics

Turnstone Biologics is a New York-based biotechnology company focused on developing innovative therapies to treat and cure patients with solid tumors. Their mission is to address the challenge of low numbers of tumor-reactive T cells by pioneering a differentiated approach to tumor infiltrating lymphocytes (TILs). With a seasoned management team and a distinguished Scientific Advisory Board, Turnstone is dedicated to advancing the field of immunotherapy and improving outcomes for patients with solid tumors. Turnstone Biologics is committed to developing next-generation TIL therapies, known as Selected TILs, for potential treatment across multiple solid tumors. Led by President and CEO Dr. Sammy Farah, the company brings together world-renowned professionals with deep expertise in TILs, cell therapy, tumor immunology, and biologics development. With a focus on innovation and collaboration, Turnstone is at the forefront of the fight against solid tumors, aiming to deliver on the promise of curative immunotherapies.Generated from the website

Viatris Inc, headquartered in New York, NY, is dedicated to improving global healthcare by providing high-quality medicines across a wide range of therapeutic areas, including both noncommunicable and infectious diseases. The company is committed to ensuring reliable access to treatments, empowering individuals to live healthier lives at every stage of life. With a focus on innovation and sustainability, Viatris brings together talented professionals who share a common goal of enhancing healthcare access worldwide. The company actively engages in research and development to deliver effective solutions that meet the diverse needs of patients globally. Generated from the website

Novo Nordisk of North America, based in New York, NY, is a leading pharmaceutical company specializing in disease areas such as diabetes and cardiovascular health. With a focus on science, technology, and sustainable business practices, Novo Nordisk offers a range of innovative products to patients worldwide. Through partnerships, research and development, and a commitment to prevention, Novo Nordisk continues to make strides in the healthcare industry. The company's dedication to improving patient outcomes and investing in cutting-edge treatments underscores its position as a global leader in the field of pharmaceuticals. Generated from the website